Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,101,472
  • Shares Outstanding, K 2,407,623
  • Annual Sales, $ 88,821 M
  • Annual Income, $ 14,066 M
  • EBIT $ 14,297 M
  • EBITDA $ 21,783 M
  • 60-Month Beta 0.51
  • Price/Sales 3.98
  • Price/Cash Flow 10.74
  • Price/Book 5.04

Options Overview Details

View History
  • Implied Volatility 15.36% ( -0.37%)
  • Historical Volatility 21.33%
  • IV Percentile 31%
  • IV Rank 25.51%
  • IV High 23.61% on 01/10/25
  • IV Low 12.53% on 05/09/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 44,450
  • Volume Avg (30-Day) 48,247
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 385,754
  • Open Int (30-Day) 395,808

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.60
  • Number of Estimates 7
  • High Estimate 2.67
  • Low Estimate 2.51
  • Prior Year 2.71
  • Growth Rate Est. (year over year) -4.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
140.68 +6.90%
on 01/10/25
153.45 -2.00%
on 01/27/25
+5.33 (+3.67%)
since 12/27/24
3-Month
140.68 +6.90%
on 01/10/25
162.17 -7.27%
on 10/29/24
-11.22 (-6.94%)
since 10/28/24
52-Week
140.68 +6.90%
on 01/10/25
168.85 -10.94%
on 09/04/24
-9.12 (-5.72%)
since 01/26/24

Most Recent Stories

More News
AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results?

AbbVie ABBV is set to report fourth-quarter and full-year 2024 earnings on Jan. 31, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $14.92 billion...

JNJ : 150.38 (-1.64%)
ABBV : 174.81 (-1.18%)
RHHBY : 38.9400 (-0.41%)
Is ISRG a Buy After Logging Robust System Placements in Q4?

During the fourth quarter, Intuitive Surgical ISRG placed 493 systems, up 19% from 415 in the year-ago period. Total system placements were record-high in the past year.  This includes 284 systems placed...

JNJ : 150.38 (-1.64%)
MDT : 91.98 (-0.52%)
ISRG : 574.14 (+0.12%)
Technology Stocks Upended by China’s DeepSeek

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -1.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.97%. March E-mini...

MSTR : 335.93 (-3.45%)
JNJ : 150.38 (-1.64%)
KHC : 29.59 (-2.02%)
COIN : 281.82 (+1.38%)
AMD : 114.17 (-0.73%)
SPY : 604.52 (+0.86%)
PTLO : 14.48 (+8.18%)
HCA : 328.70 (-0.99%)
MU : 88.25 (-3.14%)
CAG : 25.61 (-2.29%)
AMT : 186.93 (-2.66%)
ORCL : 164.00 (+3.61%)
How to Play J&J Stock After Q4 Beat & Soft 2025 Sales Guidance

Key TakeawaysJNJ beat Q4 earnings and sales estimates, with its Innovative Medicines Unit outperforming expectations.Sales in the unit rose 4.4% YOY to $14.33 billion, led by key drugs such as Darzalex,...

ITCI : 127.00 (-0.17%)
JNJ : 150.38 (-1.64%)
KVUE : 21.36 (-0.37%)
AMGN : 280.30 (-0.94%)
Stocks Hit by AI Jitters

The S&P 500 Index ($SPX ) (SPY ) today is down -1.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.68%. March E-mini S&P futures...

MSTR : 335.93 (-3.45%)
AMAT : 172.85 (-0.99%)
CVS : 57.33 (+2.01%)
AVGO : 207.36 (+2.59%)
KHC : 29.59 (-2.02%)
JNJ : 150.38 (-1.64%)
$IUXX : 21,463.04 (+1.59%)
COIN : 281.82 (+1.38%)
UNH : 542.48 (-0.19%)
ASML : 683.35 (-0.99%)
ZNH25 : 109-010s (-0.11%)
ESH25 : 6,097.00s (+0.83%)
Stocks Slump as China’s DeepSeek Rattles Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -1.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.66%. March E-mini S&P futures...

MSTR : 335.93 (-3.45%)
AMAT : 172.85 (-0.99%)
GOOGL : 195.30 (+1.82%)
AVGO : 207.36 (+2.59%)
KHC : 29.59 (-2.02%)
JNJ : 150.38 (-1.64%)
$IUXX : 21,463.04 (+1.59%)
COIN : 281.82 (+1.38%)
UNH : 542.48 (-0.19%)
ASML : 683.35 (-0.99%)
ZNH25 : 109-010s (-0.11%)
MSFT : 447.20 (+2.91%)
Why Traders Are Buying the Dip on Johnson & Johnson Stock

Shares of Johnson & Johnson stock have declined by 11.5% in the quarter, and markets are calling for a bottom and rally here.

JNJ : 150.38 (-1.64%)
These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. It's often looked at as a proxy for the market, since its components' performance is indicative of what's happening in the...

JNJ : 150.38 (-1.64%)
MRK : 97.45 (-0.50%)
NKE : 74.39 (-1.57%)
AMGN : 280.30 (-0.94%)
BA : 177.78 (+1.50%)
Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

This week, J&J JNJ announced fourth-quarter and full-year 2024 results, starting the earnings season for the drug and biotech sector. The FDA granted approval to AstraZeneca AZN and partner Daiichi’s...

AZN : 69.59 (-0.70%)
JNJ : 150.38 (-1.64%)
ABBV : 174.81 (-1.18%)
SNY : 52.97 (-0.69%)
Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

ABT : 127.39 (-1.58%)
JNJ : 150.38 (-1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 154.80
2nd Resistance Point 153.89
1st Resistance Point 152.13
Last Price 150.38
1st Support Level 149.46
2nd Support Level 148.55
3rd Support Level 146.79

See More

52-Week High 168.85
Fibonacci 61.8% 158.09
Fibonacci 50% 154.76
Fibonacci 38.2% 151.44
Last Price 150.38
52-Week Low 140.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar